A serial case of Japanese encephalitis in West Kalimantan
Abstract
Japanese encephalitis (JE) is an important, vaccine-preventable cause of viral encephalitis in Asia. This medical condition has a high morbidity and mortality rate, remains an under-recognized cause of encephalitis, with high rate of mortality and severe sequelae in children, especially in West Kalimantan. However, poor surveillance has made the burden difficult to quantify, hindering decisions about subsidized vaccine introduction.
In this serial case, the most common clinical presentations of JE were fever, altered mental status, seizures, vomiting, and positive meningeal irritation signs or pathologic reflexes. The JE mortality rate was as high as 40%. These highlight the need of disease surveillance, diagnostic kits supply, and health education to increase public disease awareness.
References
2. Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89:766-74, 774A-774E. DOI: https://doi.org/10.2471/BLT.10.085233
3. Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis. 2009;15:1-7. DOI: https://doi.org/10.3201/eid1501.080311
4. Kementerian Kesehatan Republik Indonesia. Japanese enchepalitis berkorelasi dengan banyaknya area persawahan, peternakan babi dan burung rawa. [cited 2022 August 3]. Available from: https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20170403/5320331/japanese-enchepalitis-berkorelasi-banyaknya-area-persawahan-peternakan-babi-dan-burung-rawa/
5. Diptyanus A, Herini ES, Indarjulianto S, Satoto TBT. The detection of Japanese encephalitis virus in Megachiropteran bats in West Kalimantan, Indonesia: A potential enzootic transmission pattern in the absence of pig holdings. Int J Parasitol Parasites Wildl. 2021;14:280–6. DOI: https://doi.org/10.1016/j.ijppaw.2021.03.009
6. Chen HL, Chang JK, Tang RB. Current recommendations for the Japanese encephalitis vaccine. J Chin Med Assoc. 2015;78:271-5. DOI: https://doi.org/10.1016/j.jcma.2014.12.009
7. World Health Organization. Japanese Encephalitis Vaccines: WHO position paper. 2015 Feb;90 (?09)?:69-88. Available from: https://apps.who.int/iris/handle/10665/242325
8. Kementrian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/117/2017 tentang Pelaksanaan Kampanye dan Introduksi Imunisasi Japanese encephalitis di Provinsi Bali. [cited 2022 August 3]. Available from: http://hukor.kemkes.go.id/uploads/produk_hukum/KMK_No._HK_.01_.07-MENKES-117-2017_ttg_Kampanye_dan_Introduksi_Imunisasi_Japanese_Enchephalistis_Bali_.pdf
9. Singh LS, Singh HL, Thokchom N, Manojkumar Singh RK. A descriptive study on prevalence pattern of Japanese encephalitis in State of Manipur. Indian J Med Microbiol. 2019;37:235-40. DOI: https://doi.org/10.4103/ijmm.IJMM_18_180
10. Gupta A, Laha S, Barik KL. Japanese encephalitis in children from an endemic district of West Bengal, India: a hospital based observational study. Asian J Med Sci. 2021;12:34–8. DOI: https://doi.org/10.3126/ajms.v12i10.37395
11. Nanishi E, Hoshina T, Sanefuji M, Kadoya R, Kitazawa K, Arahata Y, et al. A nationwide survey of pediatric-onset Japanese encephalitis in Japan. Clin Infect Dis. 2019;68:2099-104. DOI: https://doi.org/10.1093/cid/ciy816
12. Chanama S, Sukprasert W, Sa-ngasang A, A-nuegoonpipat A, Sangkitporn S, Kurane I, et al. Detection of Japanese encephalitis (JE) virus-specific IgM in cerebrospinal fluid and serum Samples from JE patients. Jpn J Infect Dis. 2005;58:294-6. PMID: 16249624
13. Centers for Disease Control and Prevention. Japanese encephalitis virus. [cited 2022 August 3]. Available from: https://www.cdc.gov/japaneseencephalitis/index.html
Copyright (c) 2024 Nathania Thedra, Evelyn Phangkawira
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2024-10-14
Published 2024-10-14
